219 related articles for article (PubMed ID: 31645276)
1. Osteonecrosis and osteomyelitis of the jaw associated with tumour necrosis factor-alpha (TNF-α) inhibitors: a systematic review.
Sacco R; Shah S; Leeson R; Moraschini V; de Almeida Barros Mourão CF; Akintola O; Lalli A
Br J Oral Maxillofac Surg; 2020 Jan; 58(1):25-33. PubMed ID: 31645276
[TBL] [Abstract][Full Text] [Related]
2. The role of illicit drugs in developing medication-related osteonecrosis (MRONJ): a systematic review.
Sacco R; Ball R; Barry E; Akintola O
Br J Oral Maxillofac Surg; 2021 May; 59(4):398-406. PubMed ID: 33789811
[TBL] [Abstract][Full Text] [Related]
3. A systematic review of metastatic cancer presenting in osteonecrosis of the jaws (MC-ONJ) in patients undergoing antiresorptive and/or antiangiogenic therapy for skeletal-related adverse events.
Sacco R; Woolley J; Yates J; Calasans-Maia MD; Akintola O; Patel V
Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Jun; 131(6):650-659. PubMed ID: 33518491
[TBL] [Abstract][Full Text] [Related]
4. Osteonecrosis of the jaw in patients with inflammatory bowel disease treated with tumour necrosis factor alpha inhibitors.
Brijs K; Miclotte I; Vermeire S; Darche V; Politis C
Int J Oral Maxillofac Surg; 2020 Mar; 49(3):317-324. PubMed ID: 31466830
[TBL] [Abstract][Full Text] [Related]
5. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
[TBL] [Abstract][Full Text] [Related]
6. Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings.
Hoefert S; Schmitz I; Tannapfel A; Eufinger H
Clin Oral Investig; 2010 Jun; 14(3):271-84. PubMed ID: 19536569
[TBL] [Abstract][Full Text] [Related]
7. Surgically treated osteonecrosis and osteomyelitis of the jaw and oral cavity in patients highly adherent to alendronate treatment: a nationwide user-only cohort study including over 60,000 alendronate users.
Eiken PA; Prieto-Alhambra D; Eastell R; Abrahamsen B
Osteoporos Int; 2017 Oct; 28(10):2921-2928. PubMed ID: 28664276
[TBL] [Abstract][Full Text] [Related]
8. The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk Factors.
Dodson TB
Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):509-16. PubMed ID: 26362367
[TBL] [Abstract][Full Text] [Related]
9. Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review.
Nicolatou-Galitis O; Kouri M; Papadopoulou E; Vardas E; Galiti D; Epstein JB; Elad S; Campisi G; Tsoukalas N; Bektas-Kayhan K; Tan W; Body JJ; Migliorati C; Lalla RV;
Support Care Cancer; 2019 Feb; 27(2):383-394. PubMed ID: 30353228
[TBL] [Abstract][Full Text] [Related]
10. Osteonecrosis of the Jaw in Patients Receiving Bone-Targeted Therapies: An Overview--Part I.
Turner B; Drudge-Coates L; Ali S; Pati J; Nargund V; Ali E; Cheng L; Wells P
Urol Nurs; 2016; 36(3):111-6, 154. PubMed ID: 27501591
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of segmental mandibular resection without microvascular reconstruction in patients affected by medication-related osteonecrosis of the jaw: a systematic review.
Sacco R; Umar G; Guerra RC; Akintola O
Br J Oral Maxillofac Surg; 2021 Jul; 59(6):648-660. PubMed ID: 34023155
[TBL] [Abstract][Full Text] [Related]
12. Emerging therapies with potential risks of medicine-related osteonecrosis of the jaw: a review of the literature.
Kanwar N; Bakr MM; Meer M; Siddiqi A
Br Dent J; 2020 Jun; 228(11):886-892. PubMed ID: 32541753
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous bilateral osteonecrosis of the mandible in a bisphosphonate-naive patient.
Sklavos AW; Delpachitra SN; Thomas AM; Nastri A
Br J Oral Maxillofac Surg; 2019 Apr; 57(3):271-274. PubMed ID: 30773304
[TBL] [Abstract][Full Text] [Related]
14. Antiresorptive Agent-Related Osteonecrosis of the Jaw (ARONJ): A Twist of Fate in the Bone.
Shibahara T
Tohoku J Exp Med; 2019 Feb; 247(2):75-86. PubMed ID: 30713280
[TBL] [Abstract][Full Text] [Related]
15. Systematic review of medication related osteonecrosis of the jaw (MRONJ) in patients undergoing only antiangiogenic drug therapy: surgery or conservative therapy?
Sacco R; Woolley J; Patel G; Calasans-Maia MD; Yates J
Br J Oral Maxillofac Surg; 2022 Feb; 60(2):e216-e230. PubMed ID: 35115201
[TBL] [Abstract][Full Text] [Related]
16. Medication-Related Osteonecrosis of the Jaw Associated in a Patient Treated With Etanercept.
Nisi M; Izzetti R; Graziani F
J Craniofac Surg; 2022 Oct; 33(7):e694-e696. PubMed ID: 35184115
[TBL] [Abstract][Full Text] [Related]
17. Raloxifene-induced osteonecrosis of the jaw (MRONJ) with no exposure to bisphosphonates: clinical and radiographic findings.
Bindakhil M; Shanti RM; Mupparapu M
Quintessence Int; 2021; 52(3):258-263. PubMed ID: 33491398
[TBL] [Abstract][Full Text] [Related]
18. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P
Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
[TBL] [Abstract][Full Text] [Related]
19. Medication-related osteonecrosis of the jaw: A literature review.
Kuroshima S; Sasaki M; Sawase T
J Oral Biosci; 2019 Jun; 61(2):99-104. PubMed ID: 31109863
[TBL] [Abstract][Full Text] [Related]
20. Review and update on drugs related to the development of osteonecrosis of the jaw.
Eguia A; Bagán-Debón L; Cardona F
Med Oral Patol Oral Cir Bucal; 2020 Jan; 25(1):e71-e83. PubMed ID: 31880288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
